Kaplan–Meier survival analysis indicated that cancer patients with elevated NUPR1 expression in macrophages experienced significantly shorter OS (Figure 7O), underscoring the potential of NUPR1+ macrophages as a biomarker for predicting resistance to cancer immunotherapy. Here, NUPR1 is linked to cancer.